These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19451796)

  • 41. Cryptococcal Meningitis Presenting as a Complication in HIV-infected Children: A Case Series From Sub-Saharan Africa.
    Nyazika TK; Masanganise F; Hagen F; Bwakura-Dangarembizi MF; Ticklay IM; Robertson VJ
    Pediatr Infect Dis J; 2016 Sep; 35(9):979-80. PubMed ID: 27187754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
    Deiss R; Loreti CV; Gutierrez AG; Filipe E; Tatia M; Issufo S; Ciglenecki I; Loarec A; Vivaldo H; Barra C; Siufi C; Molfino L; Tamayo Antabak N
    PLoS One; 2021; 16(4):e0250195. PubMed ID: 33901215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis.
    Sungkanuparph S; Vibhagool A; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C
    AIDS; 2003 Sep; 17(14):2129-31. PubMed ID: 14502020
    [No Abstract]   [Full Text] [Related]  

  • 44. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
    Kendi C; Penner J; Koech J; Nyonda M; Cohen CR; Bukusi EA; Ngugi E; Meyer AC
    Postgrad Med J; 2013 Feb; 89(1048):73-7. PubMed ID: 23112217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study.
    Wu L; Xiao J; Song Y; Gao G; Zhao H
    BMC Infect Dis; 2020 Dec; 20(1):912. PubMed ID: 33261581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
    Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
    Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comment on "cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
    Joob B; Wiwanitkit V
    J Int AIDS Soc; 2012; 15(2):17977. PubMed ID: 22905364
    [No Abstract]   [Full Text] [Related]  

  • 48. Burden of cryptococcal meningitis in Malawi.
    Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of three opportunistic infections in an outpatient HIV clinic in Jamaica.
    Barrow G; Clarke TR; Carrington D; Harvey K; Barton EN
    West Indian Med J; 2010 Jul; 59(4):393-9. PubMed ID: 21355514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
    Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
    BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
    Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
    J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to comment on "prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012; 15(2):18003. PubMed ID: 22905363
    [No Abstract]   [Full Text] [Related]  

  • 53. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
    Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
    Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryptococcal infection in HIV-infected patients with CD4
    Pérez-Jacoiste Asín MA; Bisbal O; Iribarren JA; Pérez-Rivilla A; Mican R; Dronda F; González-Domenech CM; Vinuesa-García D; Macías J; Lumbreras C; Moreno S; Rubio R;
    Clin Microbiol Infect; 2021 Aug; 27(8):1171.e1-1171.e7. PubMed ID: 33069858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human immunodeficiency virus (HIV) related cryptococcal meningitis in rural central Thailand--treatment difficulties and prevention strategies.
    Wright P; Inverarity D
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):58-61. PubMed ID: 17539247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptococcal meningitis in AIDS.
    Spec A; Powderly WG
    Handb Clin Neurol; 2018; 152():139-150. PubMed ID: 29604972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
    Chronister CL
    Optometry; 2006 Sep; 77(9):438-45. PubMed ID: 16939885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
    Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
    PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.